Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11560372
Heterocyclic compounds useful as modulators of acetylcholine receptors
granted -
US 11560381
Compounds and uses thereof
granted -
AU 2021290177
A recombinant Modified Vaccinia Virus Ankara (MVA) vaccine against coronavirus disease
granted -
CA 3222905
UTILISATION DE SOUCHES BACTERIENNES DE LACTOBACILLUS PARACASEI DANS LE TRAITEMENT DE NOUVEAU-NES
granted -
US 11554103
Compositions and methods to reduce pharmaceutical-induced toxicity
granted -
US 11554180
Adeno-associated virus virions with variant capsid and methods of use thereof
granted -
US 11555068
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11554101
Process for encapsulating soluble biologics, therapeutics, and imaging agents
granted -
US 11554114
Methods and compositions for self-regulated release of active pharmaceutical ingredients
granted -
US 11554140
Nucleic acid, chimeric antigen receptor expression plasmid, chimeric antigen receptor expressing cell, use thereof, and pharmaceutical composition for treating cancer
granted -
US 11555055
Peptide inhibitors of insulin-degrading enzyme
granted -
US 11555189
Antisense oligomer compounds
granted -
US 11555056
Methods and materials for treating cancer
granted -
US 11554168
HIV vaccines comprising one or more population episensus antigens
granted -
US 11555021
Fatty acid derivatives and their use
granted -
US 11555041
Bridged bicyclic inhibitors of menin-MLL and methods of use
granted -
US 11555060
QTY FC fusion water soluble receptor proteins
granted -
US 11555057
Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5
granted -
US 11555064
Treating headache comprising administering an antibody to calcitonin gene-related peptide
granted -
US 11554102
Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders
granted -
US 11549112
RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of use
granted -
US 11548890
HPK1 antagonists and uses thereof
granted -
US 11548899
Fused 1,4-oxazepines and related analogs as BET bromodomain inhibitors
granted -
US 11548947
Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.